APS arthritis guidelines
This article was originally published in The Tan Sheet
Executive Summary
Adults with osteoarthritis "should be encouraged to take 1,500 mg oral glucosamine sulfate daily," American Pain Society advises in recent "Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis & Juvenile Chronic Arthritis." For chondroitin and SAM-e, APS concludes "until there have been longer-term studies and more standardization of dosages...no recommendations can be made about their use." Acetaminophen remains "drug of choice" for mild to moderate arthritis pain, APS says, due to analgesic's mild side effects, OTC availability and low cost. However, guidelines note long-term use may be associated with chronic kidney failure, although effect is likely to be "very rare." Guidelines represent first evidence-based, multidisciplinary arthritis pain recommendations ever issued by APS...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.